In response to Morris et al.'s "Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine".
Gillman
Ken
K
D014150:Antipsychotic Agents / Q000506:poisoning*; D001569:Benzodiazepines / Q000506:poisoning*; D001971:Bromocriptine / Q000627:therapeutic use; D002746:Chlorpromazine / Q000506:poisoning*; D018450:Disease Progression; D018491:Dopamine Agonists / Q000627:therapeutic use; D062787:Drug Overdose; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy / Q000209:etiology*; D000077152:Olanzapine; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D017366:Serotonin Receptor Agonists; D001569:Benzodiazepines; D001971:Bromocriptine; D000077152:Olanzapine; D002746:Chlorpromazine